Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry

Back

ESC Professional Premium Access

Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry

Session: Acute and chronic pericarditis: how to best manage your patients

Topic: Pericarditis

Speaker: Doctor P. Cremer (Cleveland, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Paul Cremer

Cleveland Clinic, Cleveland (United States of America)

15 presentations

0 follower

9 more presentations in this session

A novel risk-stratification model that predicts long-term clinical outcomes in patients with recurrent pericarditis

Speaker: Doctor A. Kumar (Washington, DC, US)

Whole exome sequencing in patients with recurrent pericarditis

Speaker: Doctor V. Collini (Udine, IT)

Prognostic factors and etiological insights in constrictive pericarditis

Speaker: Doctor L. Admella Severiano (Barcelona, ES)

Short-pulse of systemic steroids in acute pericarditis: an alternative in refractory cases

Speaker: Doctor A. Sanchez Arjona (Majadahonda, ES)

Multi-year recurrent pericarditis disease duration in Italian patients: clinical outcomes after cessation of long-term IL-1 pathway inhibition provide insights for chronic management

Speaker: Doctor M. Imazio (Udine, IT)

Access the full session

Acute and chronic pericarditis: how to best manage your patients

Speakers: Doctor P. Cremer, Doctor A. Kumar, Doctor V. Collini, Doctor L. Admella Severiano, Doctor A. Sanchez Arjona...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources